NCI Recognizes Community Physician J. Philip Kuebler
The 2011 Harry Hynes Award, which recognizes excellence in research within the Community Clinical Oncology Program (CCOP) Network, has been awarded to Dr. J. Philip Kuebler, the principal investigator of the Columbus CCOP, in Columbus, OH.
Dr. Kuebler has been the principal investigator for the Columbus CCOP since 1998 and active in clinical trials research for more than 30 years. He has served as a protocol coordinator for a large adjuvant colon cancer treatment trial and represented community-based medical oncologists on the NCI Gastrointestinal Cancer Steering Committee and the Cancer and Leukemia Group B Data and Safety Monitoring Board.
The CCOP program established the Harry Hynes Award in 2001 to recognize and acknowledge outstanding commitment by community investigators to clinical research. The award was named for Dr. Harry Hynes, the principal investigator of the Wichita Community Clinical Oncology Program, for his tremendous dedication and commitment to bringing clinical trials to the community setting.
Meet NCI Experts at the American Public Health Association Annual Meeting
NCI will participate in the American Public Health Association (APHA) 139th Annual Meeting, which will be held October 29–November 2 at the Walter E. Washington Convention Center in Washington, DC.
APHA attendees can learn more about NCI's funding opportunities, staff, research, cancer control programs, and fellowships. Attendees can also connect with NCI staff during the special career and funding networking session, attend sessions involving NCI staff, and visit with NCI staff at NCI Exhibit Booth #5081 during the Meet the Experts Sessions.
For a list of sessions with NCI staff and activities at NCI's exhibit booth, visit NCI's APHA 2011 webpage.
Summit on Cell Therapy for Cancer Slated for November
The Society for Immunotherapy of Cancer (SITC) and the NIH Department of Transfusion Medicine will present the Summit on Cell Therapy for Cancer November 1–2 in Masur Auditorium on the NIH campus.
This program is part of the SITC 26th Annual Meeting & Associated Programs, scheduled to take place November 1–6 in Bethesda, MD.
The summit includes a mix of perspectives, concepts, and techniques related to cell therapy. Topics include:
- Induced pluripotent stem cells
- Reprogramming immune cells and translational considerations
- Various cell therapy modalities
- Regulatory considerations for cell therapies
- Methods for T-cell expansion
- Evaluation of biomarkers for T-cell therapies
- Adoptive immune therapies for melanoma
- Persistence of transferred cells
- Differentiation of human and mouse immune stem cells
- Clinical trials that will affect cell therapies: The CITN perspective
Dr. Mahendra Rao of the NIH Center for Regenerative Medicine and Dr. Steven Rosenberg of NCI's Center for Cancer Research will give keynote addresses.
Registration is required to attend this event, as seating is limited. Registration is free for government employees.
For more information about the Summit on Cell Therapy for Cancer or the SITC annual meeting, visit the SITC website.